
Sign up to save your podcasts
Or


BofA analyst Geoff Meacham talks about downgrading Pfizer, upgrading Merck, and what he thinks will become the best selling medicine of all time.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Barron's4.7
15081,508 ratings
BofA analyst Geoff Meacham talks about downgrading Pfizer, upgrading Merck, and what he thinks will become the best selling medicine of all time.
Learn more about your ad choices. Visit megaphone.fm/adchoices

3,228 Listeners

1,713 Listeners

518 Listeners

977 Listeners

4,420 Listeners

2,175 Listeners

686 Listeners

1,044 Listeners

378 Listeners

213 Listeners

934 Listeners

1,320 Listeners

114 Listeners

212 Listeners

73 Listeners

80 Listeners

150 Listeners

20 Listeners

47 Listeners